Pfizer Says COVID-19 Pill Near 90% Effective in Final Analysis
Pfizer on Tuesday said final analysis of its antiviral COVID-19 pill still showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent lab data suggests the drug retains its effectiveness against the fast-spreading omicron variant of the coronavirus. That's literally a game-changer!
Photo Credit: Julia Zolotova